You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Desmoplastic Small Round Cell Tumor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Tumor treating fields（EFE-P100）
  • Docetaxel injection
  • Shanghai, China
    Shanghai Pulmonary Hospital
Dec 21, 2022

Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • carboplatin chemotherapy
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 3, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Circulating Tumor DNA After Stereotactic Ablative Radiotherapy

Recruiting
  • Non Small Cell Lung Cancer
    • London, Ontario, Canada
      London Health Sciences Centre
    Jun 19, 2023

    Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

    Recruiting
    • Small Cell Lung Cancer
    • Neuroendocrine Carcinoma
    • Chiba, Japan
    • +1 more
    Jan 16, 2023

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Pathological Tumor and Lymph Node Responses After Neoadjuvant

    Completed
    • Non Small Cell Lung Cancer
    • +3 more
    • Timing of drug administration
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

    Recruiting
    • Refractory Solid Tumor
    • +4 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 4, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumor
    • +7 more
    • WM-A1-3389
    • Pembrolizumab
    • Seoul, Seocho-gu, Korea, Republic of
    • +1 more
    May 14, 2023

    Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

    Recruiting
    • Lung Cancer
      • Shanghai, China
        Shanghai Chest Hospital
      Jul 20, 2023

      Blood Samples in Patients With Non-small Cell Lung Cancer

      Recruiting
      • Stage III Non-Small Cell Lung Cancer AJCC v7
      • +3 more
      • Biospecimen Collection
      • Laboratory Biomarker Analysis
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Nov 18, 2022

      Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)

      Not yet recruiting
      • Advanced Non-Small Cell Squamous Lung Cancer
      • +2 more
      • CTV omitted or delineated
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Sep 7, 2023

      NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +32 more
      • (no location specified)
      Mar 30, 2023

      Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

      Not yet recruiting
      • Lung Neoplasm
      • +2 more
      • Tumor samples
      • Bordeaux, France
        CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
      Aug 28, 2023

      SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

      Recruiting
      • SCLC
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +5 more
      • Duarte, California
      • +1 more
      Dec 7, 2022

      NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Circulating tumor DNA treatment monitoring
      • Naestved, Zealand, Denmark
      • +2 more
      May 25, 2023

      Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

      Active, not recruiting
      • Urinary Bladder Cancer
      • +9 more
      • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
      • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
      • Miami, Florida
      • +10 more
      Aug 9, 2022

      Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

      Not yet recruiting
      • Lung Non-Small Cell Carcinoma
      • +3 more
      • Pulmonary Artery-First Surgical Technique
      • Biospecimen Collection
      • (no location specified)
      Aug 15, 2022

      NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)

      Recruiting
      • Non-small Cell Lung Cancer
      • L-TIL, Tislelizumab, Docetaxel
      • Zhengzhou, Henan, China
        No.127 Dongming Road
      May 17, 2023

      Lung Tumor Protein Synthesis Rates in Lung Cancer Patients

      Recruiting
      • Lung Cancer
      • There are no interventions in the present study
      • Heerlen, Limburg, Netherlands
        Zuyderland Medical Center
      Mar 31, 2023

      Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      NSCLC Trial in Munich (Bone marrow aspiration from the iliac crest, Illinois bone marrow aspiration neddle)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Bone marrow aspiration from the iliac crest
      • Illinois bone marrow aspiration neddle
      • Munich, Germany
        Division of Thoracic Surgery, Technical University of Munich, Mu
      May 16, 2022

      Lung Cancer Trial (ortataxel)

      Completed
      • Lung Cancer
      • (no location specified)
      Sep 23, 2022